AstraZeneca offloads inhalers in $270M deal
To view this email as a web page, click here

Today's Rundown

Featured Story

AbbVie's Parkinson's pump hits goal in phase 3, setting stage for approval filings

AbbVie’s bid to cannibalize its own Parkinson’s disease business has advanced, with the phase 3 success of subcutaneous, pump-delivered levodopa-carbidopa formulation ABBV-951 providing the backbone of planned approval filings.

read more

Top Stories

Stallergenes, seeking an edge in a competitive space, taps Aptar for connected drug delivery project

Stallergenes Greer has identified drug delivery as a way to differentiate its allergen immunotherapies from rival products, leading it to partner with Aptar Pharma to develop a connected device.

read more

AstraZeneca resumes asset sale in $270M COPD deal with familiar buyer Covis

Over the years, AstraZeneca has consistently adjusted its portfolio, targeting ageing products. The company has now found a new home for two respiratory meds with an old buyer, which together turned in $143 million in sales last year.

read more

Meissa posts early clinical data on nasal COVID-19 vaccine, providing support for role in breaking transmission chains

Meissa Vaccines has presented early clinical data on its nasal COVID-19 vaccine, revealing the highest dose of the recombinant live attenuated candidate triggered similar nasal antibody levels to natural immunity.

read more

A COVID-19 vaccine delivered with a patch rivals traditional shots in mice: study

Researchers at University of Queensland collaborated with Vaxxas to develop a COVID-19 patch that warded off the virus in mice. They hope to raise funding to bring the patch into clinical testing but are facing competition from existing vaccines and other patch developers.

read more

Resources

Whitepaper: Create a seamless experience across eConsent, eCOA & more

Find out how to improve clinical protocol adherence, and thus patient outcomes, by 15%+ with Medable’s latest White Paper.

2021 Report: Clinical Trial Management in a Post-Pandemic World

New market research provides valuable insight into the impact of adaptations made in clinical trials during the pandemic.

Whitepaper: A Checklist for eCOA Solution Deployment

Every detail is important when selecting a new eCOA solution; learn more about the current eCOA landscape, best practices, and crucial considerations for successful eCOA solution deployment in this white paper.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Content Hub: Remarque Systems Resource Hub

Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. 

Events